BridgeMD
New treatment option for Perimenopause
Official title Amygdala Insula Retraining in the Management of Perimenopause Symptoms
ClinicalTrials.gov ID: NCT07427459
What this study is testing
- What it's testing
- The goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms. Our research questions include: Does AIR reduce overall perimenopausal symptom burden compared to a wait-list control?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 38 to 60, women only
You may be able to join if
- Experiencing perimenopausal symptoms
- Meets STRAW+10 criteria based on self-assessment (-2 to +1c)
- Able to read and understand English
- Access to internet
You likely can't join if
- Pregnancy
- Presence of a severe psychiatric condition requiring immediate clinical intervention
- Uncontrolled thyroid disease or prolactinoma
- Active cancer treatment
- Inability to provide informed consent
- Any medical or psychiatric condition that, in the judgment of the investigator or study team, would interfere with safe participation or study...
The study team makes the final eligibility decision.
Where it's taking place
- Decorah, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 38 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Decorah, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.